Start Date
January 31, 2003
Primary Completion Date
October 31, 2004
Study Completion Date
October 31, 2004
carboplatin
paclitaxel
paclitaxel poliglumex
Virginia Oncology Care P.C., Richlands
Santee Hematology Oncology, Sumter
Charleston Cancer Center, Charleston
Northwest Georgia Oncology Centers, P.C., Marietta
Georgia Cancer Specialists - Tucker, Tucker
MetCare Oncology, Ormond Beach
Omni Healthcare, PA, Melbourne
New Hope Cancer Centers, Hudson
Hematology Oncology Associates of theTreasure Coast - Port St. Lucie, Port Saint Lucie
Clinical Research Consultants, Inc, Hoover
Hematology and Oncology Associates of Alabama, Birmingham
Clarksville Regional Hematology/Oncology Group, Clarksville
Family Cancer Center, Collierville
Hattiesburg Clinic, P.A., Hattiesburg
Kentucky Cancer Clinic, Pikeville
Gabrail Cancer Center - Canton Office, Canton
Grand Rapids
Gross Point Medical Center, Skokie
Silver Cross Hospital, Joliet
Columbia Comprehensive Cancer Care Clinic, Columbia
Bond Clinic, Rolla
Oklahoma Oncology, Inc. - St. John Campus, Tulsa
Cancer Therapy and Research Center, San Antonio
Arizona Clinical Research Center, Tucson
Las Vegas Cancer Center, Las Vegas
California Hematology/Oncology Medical Group, Torrance
Clinical Trials and Research Associates, Incorporated, Montebello
Synergy Hematology/Oncology Medical Associates, Encino
Holy Cross Providence Cancer Center, Mission Hills
Highline Medical Oncology, Burien
Rainier Oncology, Puyallup
Hematology Oncology, P.C., Stamford
Summit Medical Group, P.A., Summit
University of Texas - MD Anderson Cancer Center, Houston
Cross Cancer Institute, Edmonton
Lead Sponsor
CTI BioPharma
INDUSTRY